Rated 5 out of 5 Anonymous Rated 5 out of 5 Michael Adams Rated 5 out of 5 Angela C
This is particularly interesting as next-generation multi-receptor agonists that incorporate glucagon receptor agonism have shown tremendous promise for weight loss and glycemic control, including triagonists for the GLP-1R, GIPR and GCGR 44,45
Currently, there is no universally established safe level for either substance, as the appropriate levels will largely depend on the users health status and specific medical needs
However, the modest effect does not negate the potential value of these drugs, especially for conditions where few effective treatment options exist, for example, dementia, Al-Aly said
doi: 10.1038/npp.2011.318 14 BelmakerR
Theres no official rulebook on it and no studies have been done to show exactly how it works or if its safe